Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06587204 · ClinicalTrials.gov registry record · NA
Understanding Decentralized Trial Engagement and Clinical Impediments Through Digital Efforts (UDECIDE) Among Unrepresented Groups With Poor Cardiovascular and Cardiometabolic Health
A NA study of Heart Diseases, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 125
- Enrollment target
- 1
- Study location
NCT06587204: Recruiting NA study of Heart Diseases, sponsored by University of Miami.
NCT06587204 is a NA study of Heart Diseases that is actively recruiting participants, run by University of Miami. The registered enrollment target is 125 participants, below the 5,531-participant average among 85 other Heart Diseases trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06587204, a NA study of Heart Diseases, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the UDECIDE study is to demonstrate adherence to decentralized clinical trials among underrepresented groups with cardiometabolic conditions .
Primary Outcome
Will be measured in percentage
Conditions Studied
Interventions
- OTHER Control Group
- BEHAVIORAL Decentralized Group
- BEHAVIORAL Digital Literacy Navigation Group
- BEHAVIORAL Social Care Navigation Group
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2025-09-15 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT06587204 shows while recruiting
NCT06587204 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 5,531-participant average among 85 other Heart Diseases trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Heart Diseases appearing as the primary indexed condition, and to 4 interventions - of which Control Group is the first listed.
NCT06587204 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06587204 about?
NCT06587204 is a clinical study titled "Understanding Decentralized Trial Engagement and Clinical Impediments Through Digital Efforts (UDECIDE) Among Unrepresented Groups With Poor Cardiovascular and Cardiometabolic Health". The objective of the UDECIDE study is to demonstrate adherence to decentralized clinical trials among underrepresented groups with cardiometabolic conditions .
What is the current status of trial NCT06587204?
This trial is currently recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2025-09-15. Estimated completion is 2026-12-31.
What conditions does trial NCT06587204 study?
This clinical trial studies the following conditions: Heart Diseases.
What interventions are being tested in trial NCT06587204?
The interventions under investigation include: Control Group (OTHER), Decentralized Group (BEHAVIORAL), Digital Literacy Navigation Group (BEHAVIORAL), Social Care Navigation Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT06587204?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06587204 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06587204's enrollment target sits among peer trials
125 63rd of 85 higher than 23 of 85 other Heart Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Angiography and Electrogram Guided Bachmann Bundle Pacing
RECRUITING · NA
-
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
RECRUITING · NA
-
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR
RECRUITING · NA
-
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
RECRUITING · NA
-
Use of Bedside Imaging and Community Health Workers for Early Screening and Referral of Pre-symptomatic Stage B Heart Failure in the Emergency Department
RECRUITING · NA
-
Gauging Outcomes of Total Milk Ingestion on Lipid and gControl
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI